CRIS
HEALTHCARECuris Inc
$0.62+0.05 (+8.17%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CRIS Today?
No stock-specific AI insight has been generated for CRIS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.49$3.13
$0.62
Fundamentals
Market Cap$25M
P/E Ratio—
EPS$-0.58
Dividend Yield—
Dividend / Share—
ROE-29.5%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume225K
Avg Volume (10D)—
Shares Outstanding40.0M
CRIS News
20 articles- Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 7, 2026
- Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026Yahoo Finance·May 5, 2026
- Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·Apr 28, 2026
- Curis (CRIS) Upgraded to Buy: What Does It Mean for the Stock?Yahoo Finance·Apr 15, 2026
- Curis Inc (CRIS) Q4 2025 Earnings Call Highlights: A Turnaround with Strong Quarterly Profit ...Yahoo Finance·Mar 20, 2026
- Curis, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 20, 2026
- Curis (CRIS) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 19, 2026
- Curis: Q4 Earnings SnapshotYahoo Finance·Mar 19, 2026
- Curis Provides Fourth Quarter 2025 Business UpdateYahoo Finance·Mar 19, 2026
- Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026Yahoo Finance·Mar 12, 2026
- How The Curis (CRIS) Narrative Is Evolving As Assumptions Shift But The Target StaysYahoo Finance·Mar 11, 2026
- How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 TargetYahoo Finance·Feb 11, 2026
- Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value ResetYahoo Finance·Jan 11, 2026
- Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross ProceedsYahoo Finance·Jan 9, 2026
- Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross ProceedsYahoo Finance·Jan 7, 2026
- Curis Provides Updated Data from its Frontline AML Triplet StudyYahoo Finance·Dec 9, 2025
- How Recent Developments Are Shaping the Curis Investment StoryYahoo Finance·Nov 28, 2025
- Curis to Present at Upcoming 30th Annual SNO MeetingYahoo Finance·Nov 14, 2025
- Why Analysts Are Rethinking Curis After Nasdaq Warning and Price Target DropYahoo Finance·Nov 13, 2025
- Analysts Have Been Trimming Their Curis, Inc. (NASDAQ:CRIS) Price Target After Its Latest ReportYahoo Finance·Nov 9, 2025
All 20 articles loaded
Price Data
Open$0.57
Previous Close$0.57
Day High$0.63
Day Low$0.57
52 Week High$3.13
52 Week Low$0.49
52-Week Range
$0.49$3.13
$0.62
Fundamentals
Market Cap$25M
P/E Ratio—
EPS$-0.58
Dividend Yield—
Dividend / Share—
ROE-29.5%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume225K
Avg Volume (10D)—
Shares Outstanding40.0M
About Curis Inc
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—